Amneal Pharmaceuticals Inc (AMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | 796,197 | 722,519 | 814,319 | 784,513 | 724,508 |
| Cost of Goods | 461,689 | 402,406 | 517,129 | 510,539 | 438,255 |
| Gross Profit | 334,508 | 320,113 | 297,190 | 273,974 | 286,253 |
| Operating Expenses | 205,428 | 178,747 | 185,286 | 204,169 | 175,136 |
| Operating Income | 129,769 | 141,772 | 112,033 | 70,344 | 111,372 |
| Interest Expense | 55,043 | 53,361 | 56,237 | 62,814 | 65,101 |
| Other Income | -3,736 | -8,235 | -561 | -12,753 | 5,440 |
| Pre-tax Income | 70,990 | 80,176 | 55,235 | -5,223 | 51,711 |
| Income Tax | 1,376 | 2,176 | 5,662 | -23,355 | 16,101 |
| Net Income Continuous | 69,614 | 78,000 | 49,573 | 18,132 | 35,610 |
| Minority Interests | 11,952 | 15,744 | 14,497 | 15,763 | 13,193 |
| Net Income | $57,662 | $62,256 | $35,076 | $2,369 | $22,417 |
| EPS Basic Total Ops | 0.18 | 0.20 | 0.11 | 0.01 | 0.07 |
| EPS Basic Continuous Ops | 0.22 | 0.25 | 0.16 | 0.06 | 0.11 |
| EPS Diluted Total Ops | 0.18 | 0.19 | 0.10 | 0.01 | 0.07 |
| EPS Diluted Continuous Ops | 0.21 | 0.24 | 0.15 | 0.06 | 0.11 |
| EPS Diluted Before Non-Recurring Items | 0.27 | 0.25 | 0.19 | 0.15 | 0.23 |
| EBITDA(a) | $181,633 | $188,853 | $164,975 | $129,447 | $178,360 |